Soft Tissue Sarcoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients
Conditions: Soft-tissue Sarcoma; Predictive Cancer Model Interventions: Other: Care with the use of PERSARC; Other: standard care Sponsor: Leiden University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials
Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
Condition: Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients Intervention: Drug: Surufatinib + envafolimab Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2023 Category: Research Source Type: clinical trials
